Market Research Logo

Dexcel PT Israel Ltd - Strategic SWOT Analysis Review

Dexcel PT Israel Ltd - Strategic SWOT Analysis Review

provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd, develops, manufactures and markets branded and generic pharmaceuticals. Its featured products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planing and adult periodontitis; Deximune, an immunosppressant; and omeprazole delayed released tablet. The company’s other products include cetirizine, diclofenac, losartan, metoprolol tartrate, and nicorandil. Dexcel Pharma develops formulations using proprietary, patent-protected, drug delivery technologies. It offers products for allergy, analgesics, cardiovascular, dental, dermatology and pain relief, among others. The company sells its products in the US, the UK and Germany, among other countries. Dexcel Pharma is headquartered in Or Akiva, Haifa, Israel.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Dexcel PT Israel Ltd - Key Facts
Dexcel PT Israel Ltd - Key Employees
Dexcel PT Israel Ltd - Key Employee Biographies
Dexcel PT Israel Ltd - Major Products and Services
Dexcel PT Israel Ltd - Pharmaceutical Pipeline Products Data
Dexcel PT Israel Ltd, Pipeline Products by Therapy Area
Dexcel PT Israel Ltd, Pipeline Products by Development Phase
Dexcel PT Israel Ltd - History
Dexcel PT Israel Ltd - Company Statement
Dexcel PT Israel Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Dexcel PT Israel Ltd - Business Description
Dexcel PT Israel Ltd - SWOT Analysis
SWOT Analysis - Overview
Dexcel PT Israel Ltd - Strengths
Dexcel PT Israel Ltd - Weaknesses
Dexcel PT Israel Ltd - Opportunities
Dexcel PT Israel Ltd - Threats
Dexcel PT Israel Ltd - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Dexcel PT Israel Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Dexcel PT Israel Ltd, Key Facts
Dexcel PT Israel Ltd, Key Employees
Dexcel PT Israel Ltd, Key Employee Biographies
Dexcel PT Israel Ltd, Major Products and Services
Dexcel PT Israel Ltd, Number of Pipeline Products by Therapy Area
Dexcel PT Israel Ltd, Number of Pipeline Products by Development Stage
Dexcel PT Israel Ltd, History
Dexcel PT Israel Ltd, Other Locations
Dexcel PT Israel Ltd, Subsidiaries
Dexcel PT Israel Ltd, Key Competitors
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Dexcel PT Israel Ltd, Recent Deals Summary
List of Figures
Dexcel PT Israel Ltd, Pipeline Products by Therapy Area
Dexcel PT Israel Ltd, Pipeline Products by Development Phase
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report